株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

特殊ジェネリック医薬品の世界市場:産業動向、シェア、規模、成長率、機会、予測

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 821312
出版日 ページ情報 英文 106 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
特殊ジェネリック医薬品の世界市場:産業動向、シェア、規模、成長率、機会、予測 Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年04月08日 ページ情報: 英文 106 Pages
概要

当レポートでは、世界の特殊ジェネリック医薬品市場について調査分析し、産業概要、セグメント別の市場分析、競合情勢、規制、主要企業などについて、体系的な情報を提供しています。

第1章 序文

第2章 調査範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 特殊ジェネリック医薬品が有利な理由

第6章 世界の特殊ジェネリック医薬品市場

  • 市場概要
  • 市場実績
  • 市場内訳:投与経路別
  • 市場内訳:適応別
  • 市場内訳:流通経路別
  • 市場内訳:地域別
  • 市場予測
  • SWOT分析
  • バリューチェーン分析
  • ファイブフォース分析
  • 主な市場促進要因・成功要因

第7章 市場内訳:投与経路別

  • 注射用
  • 経口
  • その他

第8章 市場内訳:適応別

  • 腫瘍
  • 自己免疫疾患
  • 感染症
  • その他

第9章 市場内訳:流通経路別

  • 小売薬局
  • 特殊薬局
  • 病院薬局

第10章 市場内訳:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
図表

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2018
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2018
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2018
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2018
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 7: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 8: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 9: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2013 & 2018
  • Figure 10: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 11: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2013 & 2018
  • Figure 12: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 13: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2013 & 2018
  • Figure 14: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 15: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2013 & 2018
  • Figure 16: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 17: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2013 & 2018
  • Figure 18: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 19: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2013 & 2018
  • Figure 20: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 21: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2013 & 2018
  • Figure 22: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 23: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2013 & 2018
  • Figure 24: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2019-2024
  • Figure 25: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2013 & 2018
  • Figure 26: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2019-2024
  • Figure 27: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2013 & 2018
  • Figure 28: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2019-2024
  • Figure 29: North America: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 30: North America: Specialty Generics Market: Breakup by Country (in %), 2018
  • Figure 31: United States: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 32: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 33: Canada: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 34: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 35: Europe: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 36: Europe: Specialty Generics Market: Breakup by Country (in %), 2018
  • Figure 37: Italy: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 38: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 39: Germany: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 40: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 41: France: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 42: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 43: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 44: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 45: Spain: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 46: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 47: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 48: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2018
  • Figure 49: Japan: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 50: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 51: China: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 52: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 53: India: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 54: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 55: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 56: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 57: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 58: Latin America: Specialty Generics Market: Breakup by Country (in %), 2018
  • Figure 59: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 60: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 61: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 62: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 63: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 64: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2019-2024
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2019-2024
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2019-2024
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2019-2024
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players
目次
Product Code: SR1018F17_Report

The global specialty generics market reached a value of US$ 44.8 Billion in 2018. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc. Looking forward, the market value is further expected to reach US$ 88.9 Billion by 2024, exhibiting a CAGR of 11.9% during 2019-2024.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global smart lighting market in any manner.

Report Scope

Historical, Current and Future Market Trends

Market Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East Africa

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape

The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:

  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • \What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Market Breakup by Route of Administration
  • 6.4 Market Breakup by Indication
  • 6.5 Market Breakup by Distribution Channel
  • 6.6 Market Breakup by Region
  • 6.7 Market Forecast
  • 6.8 SWOT Analysis
    • 6.8.1 Overview
    • 6.8.2 Strengths
    • 6.8.3 Weaknesses
    • 6.8.4 Opportunities
    • 6.8.5 Threats
  • 6.9 Value Chain Analysis
  • 6.10 Porters Five Forces Analysis
    • 6.10.1 Overview
    • 6.10.2 Bargaining Power of Buyers
    • 6.10.3 Bargaining Power of Suppliers
    • 6.10.4 Degree of Competition
    • 6.10.5 Threat of New Entrants
    • 6.10.6 Threat of Substitutes
  • 6.11 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
    • 10.1.4 United States
      • 10.1.4.1 Market Trends
      • 10.1.4.2 Market Forecast
    • 10.1.5 Canada
      • 10.1.5.1 Market Trends
      • 10.1.5.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Germany
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 France
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 United Kingdom
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
    • 10.2.8 Spain
      • 10.2.8.1 Market Trends
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
    • 10.3.4 Japan
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 China
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 India
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 South Korea
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
    • 10.4.4 Brazil
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Mexico
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc.

Back to Top